Isolation of endogenous anticoagulant N-sulfated glycosaminoglycans in human plasma from healthy subjects

Pathophysiology of Haemostasis and Thrombosis

Volumn 32, Issue 1, 2002, Pages 44-49

  Ruggiero, Marco ^a   Melli, Michele ^a   Parma, Bruna ^b   Bianchini, Pietro ^b   Vannucchi, Simonetta ^a,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b Opocrin Research Laboratories   (Italy)

^c Dipto Patol e Oncol Sperimentali   (Italy)

Author keywords

Anticoagulant activity; Hemostasis; Heparin; Human plasma; Peptides

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR DYNAMICS; NORMAL HUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PURIFICATION; SULFATION; THROMBOPLASTIN TIME;

ANIMALS; ANTICOAGULANTS; BIOLOGICAL FACTORS; BLOOD COAGULATION TESTS; CATTLE; CHROMATOGRAPHY, ION EXCHANGE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBRINOLYTIC AGENTS; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; METHODS; MOLECULAR WEIGHT; NITROUS ACID; PROTEINS; REFERENCE STANDARDS;

EID: 0345411838     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057288     Document Type: Article

References (25)

1. Pasquali F, Oldani C, Ruggiero M, Magnelli L, Chiarugi V, Vannucchi S: Interaction between endogenous circulating sulfated-glycosaminoglycans and plasma proteins. Clin Chim Acta 1990;192:19-27.
2. Calatroni A, Vinci R, Ferlazzo AM: Characteristics of the interactions between acid glycosaminoglycans and proteins in normal human plasma as revealed by the behaviour of the protein-polysaccharide complexes in ultrafiltration and chromatographic procedures. Clin Chim Acta 1992;206:167-180.
3. Cherchi GM, Formato M, Demuro P, Masserini M, Varani I, DeLuca G: Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes. Biochim Biophys Acta 1994;1212:342-352.
4. Vannucchi S, Fibbi G, Pasquali F, Del Rosso M, Cappelletti R, Chiarugi V: Adhesion-dependent heparin production by platelets. Nature 1982;296:352-353.
5. Masson PJ, Coup D, Millet J, Brown NL: The effect of the beta-D-xyloside naroparcil on circulating plasma glycosaminoglycans. An explanation for its known antithrombotic activity in the rabbit. J Biol Chem 1995;270:2662-2668.
6. Palmer RN, Rick ME, Rick PD, Zeller JA, Gralnick MD: Circulating heparan sulfate anticoagulant in a patient with a fatal bleeding disorder. N Engl J Med 1984;310:1696-1699.
7. Shworak NW, Shirakawa M, Colliec-Jouault S, Liu J, Mulligan RC, Birinyi LK, Rosenberg RD: Pathway-specific regulation of the synthesis of anticoagulantly active heparan sulfate. J Biol Chem 1994;269:24941-24952.
8. Cavari S, Vannucchi S: Glycosaminoglycans exposed on the endothelial cell surface. Binding of heparin-like molecules derived from serum. FEBS Lett 1993;323:155-158.
9. Cavari S, Vannucchi S: Detection of heparin-like glycosaminoglycans in normal human plasma by polyacrylamide-gel electrophoresis. Clin Chim Acta 1996;252:159-170.
10. Snow AD, Kisilevsky R, Stephens C, Anastassiades T: Electrophoresis of glycosaminoglycans isolated from normal human plasma. Direct evidence for the presence of a heparin-like molecule. Biomed Biochim Acta 1987;46:537-546.
11. Volpi N, Cusmano M, Venturelli T: Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma. Biochim Biophys Acta 1995;1243:49-58.
12. Bianchini P, Bergonzini GL, Parma B, Osima B: Relationship between plasma antifactor Xa activity and the antithrombotic activity of heparins of different molecular mass. Haemostasis 1995;25:288-298.
13. Bradford MM: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976:72:248-254.
14. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
15. Lyon M, Gallagher JT: A general method for the detection and mapping of submicrogram quantities of glycosaminoglycan oligosaccharides on polyacrylamide gels by sequential staining with azure A and ammoniacal silver. Anal Biochem 1990;185:63-70.
16. Cappelletti R, Del Rosso M, Chiarugi V: A new method for characterization of N-sulfated glycosaminoglycans by a rapid and multisample nitrous acid treatment during an electrophoretic run and its application of the analysis of biological samples. Anal Biochem 1980;105:430-435.
17. Cavari S, Stramaccia L, Vannucchi S: Endogenous heparinase-sensitive anticoagulant activity in human plasma. Thromb Res 1992;67:157-165.
18. Teien AN, Lie M, Abildgaard U: Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb Res Suppl 1976;8:413-416.
19. Basu D, Gallus A, Hirsh J, Cade J: A prospective study of the value of monitoring heparin treatment with activated partial thromboplastin time. N Engl J Med 1972;287:324-327.
20. Handeland GF, Abildgaard U: Assay of unfractionated and LMW heparin with chromogenic substrates: Twin methods with factor Xa and thrombin. Thromb Res Suppl 1984;35:627-636.
21. Hata RI, Ohakawa SI, Nagai Y: Low-sulfated chondroitin sulfate in human blood and urine. Biochim Biophys Acta 1978;543:156-166.
22. Staprans I, Felts JM: Isolation and characterization of glycosaminoglycans in human plasma. J Clin Invest 1985;76:1984-1991.
23. Chevanne M, Caldini R, Manao G, Ruggiero M, Vannucchi S: Heparin binding peptides co-purify with glycosaminoglycans from human plasma. FEBS Lett 1999;463:121-124.
24. Horne MK 3rd, Chao ES, Wilson OJ, Scialla SJ, Lynch MA, Kragel PJJ: A heparin-like anticoagulant as part of global abnormalities of plasma glycosaminoglycans in a patient with transitional cell carcinoma. J Lab Clin Med 1991;118:250-260.
25. Bussel JB, Steinherz PG, Miller DR, Hilgartner MW: A heparin-like anticoagulant in an 8-month-old boy with acute monoblastic leukemia. Am J Pathol 1984;16:83-90.